| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | dendritic spine development | 2.22e-06 | 141 | 87 | 7 | GO:0060996 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 4.93e-06 | 225 | 87 | 8 | GO:0050905 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 1.16e-05 | 70 | 87 | 5 | GO:0060999 | |
| GeneOntologyBiologicalProcess | synaptic signaling | SHANK1 SLC6A9 RELN CDK5R1 ARID1B TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 CHRNG | 1.29e-05 | 976 | 87 | 15 | GO:0099536 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | SHANK1 SLC6A9 RELN TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 | 2.16e-05 | 663 | 87 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | SHANK1 SLC6A9 RELN TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 | 2.19e-05 | 664 | 87 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SHANK1 SLC6A9 RELN ARID1B TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 CHRNG | 3.31e-05 | 931 | 87 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SHANK1 SLC6A9 RELN ARID1B TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 CHRNG | 3.31e-05 | 931 | 87 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SHANK1 SLC6A9 RELN ARID1B TRIO TSPOAP1 MTOR ACHE GRIA1 NLGN2 ACE TNR ATP2B2 CHRNG | 3.63e-05 | 939 | 87 | 14 | GO:0099537 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 3.90e-05 | 16 | 87 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 4.16e-05 | 91 | 87 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | long-term memory | 4.99e-05 | 48 | 87 | 4 | GO:0007616 | |
| GeneOntologyBiologicalProcess | dendrite development | 8.54e-05 | 335 | 87 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 9.17e-05 | 56 | 87 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SHANK1 SPTBN5 USP10 DLG5 THBS2 CDK5R1 MTOR SPTA1 BAK1 DAAM2 RICTOR NLGN2 SIX1 ACE DYNC1H1 | 1.24e-04 | 1189 | 87 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | synapse organization | SHANK1 DLG5 RELN THBS2 CDK5R1 ACHE GRIA1 NLGN2 SIX1 TNR ATP2B2 | 1.41e-04 | 685 | 87 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | spinal cord development | 1.49e-04 | 119 | 87 | 5 | GO:0021510 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 1.56e-04 | 25 | 87 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 2.07e-04 | 69 | 87 | 4 | GO:0050881 | |
| GeneOntologyBiologicalProcess | associative learning | 2.25e-04 | 130 | 87 | 5 | GO:0008306 | |
| GeneOntologyBiologicalProcess | regulation of signaling receptor activity | 2.33e-04 | 131 | 87 | 5 | GO:0010469 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 2.57e-04 | 73 | 87 | 4 | GO:0050879 | |
| GeneOntologyBiologicalProcess | 'de novo' pyrimidine nucleobase biosynthetic process | 2.61e-04 | 6 | 87 | 2 | GO:0006207 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 2.71e-04 | 74 | 87 | 4 | GO:0050885 | |
| GeneOntologyBiologicalProcess | synapse assembly | 3.26e-04 | 308 | 87 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 4.39e-04 | 231 | 87 | 6 | GO:0032271 | |
| GeneOntologyCellularComponent | excitatory synapse | 8.94e-05 | 107 | 88 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | TORC2 complex | 6.19e-04 | 9 | 88 | 2 | GO:0031932 | |
| GeneOntologyCellularComponent | spectrin | 6.19e-04 | 9 | 88 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | bBAF complex | 7.71e-04 | 10 | 88 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.09e-03 | 48 | 88 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | TOR complex | 1.13e-03 | 12 | 88 | 2 | GO:0038201 | |
| GeneOntologyCellularComponent | npBAF complex | 1.54e-03 | 14 | 88 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.61e-03 | 405 | 88 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.62e-03 | 523 | 88 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.76e-03 | 656 | 88 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.76e-03 | 530 | 88 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.79e-03 | 658 | 88 | 9 | GO:0030312 | |
| MousePheno | abnormal forebrain morphology | SHANK1 GMNC DLG5 RELN CDK5R1 ARID1B CENPA TRIO MTOR ACHE SPTA1 SARDH HSD17B2 SIX1 SUFU TNR ATP2B2 DYNC1H1 THOC6 | 1.29e-06 | 1072 | 72 | 19 | MP:0000783 |
| MousePheno | abnormal telencephalon morphology | SHANK1 GMNC DLG5 RELN CDK5R1 ARID1B TRIO MTOR ACHE SPTA1 SARDH HSD17B2 TNR ATP2B2 DYNC1H1 THOC6 | 2.78e-06 | 812 | 72 | 16 | MP:0000787 |
| MousePheno | abnormal cerebral hemisphere morphology | SHANK1 GMNC RELN CDK5R1 ARID1B TRIO ACHE SPTA1 SARDH HSD17B2 TNR ATP2B2 DYNC1H1 | 9.96e-06 | 599 | 72 | 13 | MP:0008540 |
| MousePheno | abnormal nervous system development | SHANK1 GMNC DLG5 RELN CDK5R1 ARID1B AHI1 CENPA MTOR RTTN SMARCA4 POR MLLT10 HSD17B2 SIX1 SUFU ATP2B2 DYNC1H1 THOC6 | 1.34e-05 | 1257 | 72 | 19 | MP:0003861 |
| MousePheno | abnormal hippocampus pyramidal cell layer | 3.15e-05 | 71 | 72 | 5 | MP:0008284 | |
| MousePheno | abnormal temporal lobe morphology | 5.53e-05 | 337 | 72 | 9 | MP:0000801 | |
| MousePheno | small kidney | 6.03e-05 | 425 | 72 | 10 | MP:0002989 | |
| MousePheno | abnormal cerebellar granule layer morphology | 7.50e-05 | 85 | 72 | 5 | MP:0000886 | |
| MousePheno | slow extinction of fear memory | 7.82e-05 | 3 | 72 | 2 | MP:0012318 | |
| MousePheno | abnormal hippocampus layer morphology | 1.09e-04 | 92 | 72 | 5 | MP:0000813 | |
| MousePheno | decreased startle reflex | 1.50e-04 | 224 | 72 | 7 | MP:0001489 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | GMNC SLC6A9 NELL1 ARID1B AHI1 TRIO ACHE ATP8A2 SPTA1 SCNN1B RICTOR CALCRL SIX1 SUFU SIX2 DYNC1H1 CHRNG | 1.90e-04 | 1269 | 72 | 17 | MP:0011111 |
| MousePheno | abnormal startle reflex | SHANK1 SEC61A2 ARID1B ATP8A2 SPTA1 WDR81 GRIA1 NLGN2 ADGRV1 SUFU ATP2B2 | 2.03e-04 | 591 | 72 | 11 | MP:0001486 |
| MousePheno | abnormal reflex | SHANK1 SEC61A2 SLC6A9 NELL1 RELN ARID1B ACHE ATP8A2 SPTA1 WDR81 GRIA1 NLGN2 ADGRV1 SIX1 SUFU ATP2B2 DYNC1H1 | 2.40e-04 | 1294 | 72 | 17 | MP:0001961 |
| MousePheno | abnormal posture | 2.48e-04 | 243 | 72 | 7 | MP:0001504 | |
| MousePheno | abnormal hippocampus morphology | 2.91e-04 | 331 | 72 | 8 | MP:0000807 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 3.51e-04 | 27 | 72 | 3 | MP:0008438 | |
| MousePheno | decreased kidney weight | 3.66e-04 | 66 | 72 | 4 | MP:0003918 | |
| MousePheno | delaminated Purkinje cell layer | 3.87e-04 | 6 | 72 | 2 | MP:0000884 | |
| MousePheno | abnormal brain development | GMNC DLG5 RELN CDK5R1 ARID1B AHI1 MTOR HSD17B2 SUFU DYNC1H1 THOC6 | 3.92e-04 | 638 | 72 | 11 | MP:0000913 |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SHANK1 SEC61A2 SLC6A9 NELL1 RELN CDK5R1 ARID1B ACHE ATP8A2 SPTA1 WDR81 GRIA1 NLGN2 ADGRV1 SIX1 SUFU ATP2B2 DYNC1H1 | 4.12e-04 | 1486 | 72 | 18 | MP:0002067 |
| MousePheno | abnormal telencephalon development | 4.74e-04 | 126 | 72 | 5 | MP:0000934 | |
| MousePheno | embryonic growth retardation | DLG5 CENPA MTOR NOA1 RTTN POR RICTOR HSD17B2 SIX1 SUFU ACE THOC6 | 4.79e-04 | 763 | 72 | 12 | MP:0003984 |
| MousePheno | abnormal neuron number | 5.31e-04 | 456 | 72 | 9 | MP:0008946 | |
| Domain | Pecanex_C | 4.03e-07 | 4 | 88 | 3 | PF05041 | |
| Domain | Pecanex | 4.03e-07 | 4 | 88 | 3 | IPR007735 | |
| Domain | Spectrin | 3.80e-06 | 23 | 88 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 9.99e-06 | 29 | 88 | 4 | IPR002017 | |
| Domain | SPEC | 1.50e-05 | 32 | 88 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.50e-05 | 32 | 88 | 4 | IPR018159 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.54e-05 | 14 | 88 | 3 | PS00941 | |
| Domain | COesterase | 3.54e-05 | 14 | 88 | 3 | PF00135 | |
| Domain | CarbesteraseB | 3.54e-05 | 14 | 88 | 3 | IPR002018 | |
| Domain | ARM-like | 2.86e-04 | 270 | 88 | 7 | IPR011989 | |
| Domain | BRK | 3.25e-04 | 6 | 88 | 2 | SM00592 | |
| Domain | BRK_domain | 3.25e-04 | 6 | 88 | 2 | IPR006576 | |
| Domain | BRK | 3.25e-04 | 6 | 88 | 2 | PF07533 | |
| Domain | SIX1_SD | 4.54e-04 | 7 | 88 | 2 | IPR031701 | |
| Domain | SIX1_SD | 4.54e-04 | 7 | 88 | 2 | PF16878 | |
| Domain | SH3 | 5.50e-04 | 216 | 88 | 6 | SM00326 | |
| Domain | SH3 | 5.50e-04 | 216 | 88 | 6 | PS50002 | |
| Domain | Carboxylesterase_B_AS | 6.03e-04 | 8 | 88 | 2 | IPR019826 | |
| Domain | CARBOXYLESTERASE_B_1 | 6.03e-04 | 8 | 88 | 2 | PS00122 | |
| Domain | SH3_domain | 6.05e-04 | 220 | 88 | 6 | IPR001452 | |
| Domain | - | 6.35e-04 | 222 | 88 | 6 | 1.25.10.10 | |
| Domain | - | 1.06e-03 | 95 | 88 | 4 | 2.60.120.200 | |
| Domain | ARM-type_fold | 1.10e-03 | 339 | 88 | 7 | IPR016024 | |
| Domain | EGF_dom | 1.40e-03 | 12 | 88 | 2 | IPR024731 | |
| Domain | EGF_3 | 1.40e-03 | 12 | 88 | 2 | PF12947 | |
| Domain | Carboxylesterase_B_CS | 1.66e-03 | 13 | 88 | 2 | IPR019819 | |
| Domain | PI3/4_kinase_CS | 2.21e-03 | 15 | 88 | 2 | IPR018936 | |
| Domain | - | 2.42e-03 | 119 | 88 | 4 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 2.42e-03 | 119 | 88 | 4 | IPR029058 | |
| Domain | - | 2.52e-03 | 16 | 88 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.52e-03 | 16 | 88 | 2 | SM00146 | |
| Domain | Laminin_G | 2.59e-03 | 58 | 88 | 3 | IPR001791 | |
| Domain | EGF_extracell | 2.85e-03 | 60 | 88 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.85e-03 | 60 | 88 | 3 | PF07974 | |
| Domain | PI3_PI4_kinase | 3.20e-03 | 18 | 88 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 3.20e-03 | 18 | 88 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.20e-03 | 18 | 88 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 3.20e-03 | 18 | 88 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 3.20e-03 | 18 | 88 | 2 | PS50290 | |
| Domain | ConA-like_dom | 3.77e-03 | 219 | 88 | 5 | IPR013320 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CCDC142 PCNX2 FASN CDK5R1 NADSYN1 SYNE3 PCNX3 TRIO PIK3C2B MTOR XPO6 RTTN SREBF1 PCNX1 NLGN2 SFI1 MLLT10 SUFU ABCA7 SCARA3 DYNC1H1 | 7.75e-13 | 1105 | 91 | 21 | 35748872 |
| Pubmed | Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. | 1.73e-07 | 5 | 91 | 3 | 22521878 | |
| Pubmed | Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. | 1.49e-06 | 32 | 91 | 4 | 34193412 | |
| Pubmed | 3.75e-06 | 12 | 91 | 3 | 27307439 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 20501647 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 33281191 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 20332342 | ||
| Pubmed | mTORC2 sustains thermogenesis via Akt-induced glucose uptake and glycolysis in brown adipose tissue. | 6.77e-06 | 2 | 91 | 2 | 26772600 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28123351 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25893736 | ||
| Pubmed | Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes. | 6.77e-06 | 2 | 91 | 2 | 29857051 | |
| Pubmed | Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. | 6.77e-06 | 2 | 91 | 2 | 20226010 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18420801 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12897158 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25740823 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29099279 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 22786746 | ||
| Pubmed | Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. | 6.77e-06 | 2 | 91 | 2 | 26170313 | |
| Pubmed | Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. | 6.77e-06 | 2 | 91 | 2 | 22473959 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18831768 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 12213084 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 14535959 | ||
| Pubmed | Control of cortical neuron layering: lessons from mouse chimeras. | 6.77e-06 | 2 | 91 | 2 | 18494254 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24491563 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34541875 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 11036822 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 31073170 | ||
| Pubmed | Distinct roles of the mTOR components Rictor and Raptor in MO7e megakaryocytic cells. | 6.77e-06 | 2 | 91 | 2 | 19341427 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 20620941 | ||
| Pubmed | SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer. | 6.77e-06 | 2 | 91 | 2 | 33665967 | |
| Pubmed | Regulation of SREBP1c expression by mTOR signaling in hepatocytes. | 6.77e-06 | 2 | 91 | 2 | 20847591 | |
| Pubmed | Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides. | 6.77e-06 | 2 | 91 | 2 | 22138034 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 18281474 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 31541353 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24270265 | ||
| Pubmed | mTOR complex 2 in adipose tissue negatively controls whole-body growth. | 6.77e-06 | 2 | 91 | 2 | 19497867 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 21376236 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24105476 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25564616 | ||
| Pubmed | 1.28e-05 | 686 | 91 | 10 | 29987050 | ||
| Pubmed | 1.37e-05 | 18 | 91 | 3 | 33323119 | ||
| Pubmed | 1.44e-05 | 300 | 91 | 7 | 19086053 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23440873 | ||
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 2.03e-05 | 3 | 91 | 2 | 25385646 | |
| Pubmed | Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan. | 2.03e-05 | 3 | 91 | 2 | 25059582 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 28813526 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 21358638 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 32910019 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 2.03e-05 | 3 | 91 | 2 | 20008564 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 35982899 | ||
| Pubmed | B7-H3 regulates lipid metabolism of lung cancer through SREBP1-mediated expression of FASN. | 2.03e-05 | 3 | 91 | 2 | 27939887 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18682402 | ||
| Pubmed | Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. | 2.03e-05 | 3 | 91 | 2 | 30914315 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23049074 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 27016480 | ||
| Pubmed | Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. | 2.03e-05 | 3 | 91 | 2 | 19252981 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 38143182 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 20338997 | ||
| Pubmed | TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. | 2.03e-05 | 3 | 91 | 2 | 33416177 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 34417976 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 29328491 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19145465 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 34331380 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 31668132 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23815551 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 24563232 | ||
| Pubmed | SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer. | 2.03e-05 | 3 | 91 | 2 | 29784665 | |
| Pubmed | Genome-wide shRNA screen reveals increased mitochondrial dependence upon mTORC2 addiction. | 2.03e-05 | 3 | 91 | 2 | 21170086 | |
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 2.03e-05 | 3 | 91 | 2 | 23898069 | |
| Pubmed | Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients. | 2.03e-05 | 3 | 91 | 2 | 26476541 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 34204880 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 2.03e-05 | 3 | 91 | 2 | 19724909 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18614546 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 28027934 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 33649289 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 27690224 | ||
| Pubmed | Molecular effects of Eya1 domain mutations causing organ defects in BOR syndrome. | 2.03e-05 | 3 | 91 | 2 | 11734542 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 28128208 | ||
| Pubmed | Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells. | 2.03e-05 | 3 | 91 | 2 | 22285861 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 15735644 | ||
| Pubmed | Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. | 2.03e-05 | 3 | 91 | 2 | 26598511 | |
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 2.03e-05 | 3 | 91 | 2 | 22426308 | |
| Pubmed | mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. | 2.03e-05 | 3 | 91 | 2 | 20978191 | |
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 2.03e-05 | 3 | 91 | 2 | 23212520 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 31409773 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 14759632 | ||
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 2.03e-05 | 3 | 91 | 2 | 24958889 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12531699 | ||
| Pubmed | 2.63e-05 | 65 | 91 | 4 | 19598235 | ||
| Pubmed | Interaction between NBS1 and the mTOR/Rictor/SIN1 complex through specific domains. | 4.05e-05 | 4 | 91 | 2 | 23762398 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 28475179 | ||
| Pubmed | Cortical malformations and epilepsy: new insights from animal models. | 4.05e-05 | 4 | 91 | 2 | 10403203 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 23184344 | ||
| Pubmed | Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities. | 4.05e-05 | 4 | 91 | 2 | 19619545 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 27601681 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 23727646 | ||
| Pubmed | HCBP6 Modulates Triglyceride Homeostasis in Hepatocytes Via the SREBP1c/FASN Pathway. | 4.05e-05 | 4 | 91 | 2 | 25855506 | |
| Pubmed | CMPK1 and RBP3 are associated with corneal curvature in Asian populations. | 4.05e-05 | 4 | 91 | 2 | 24963161 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 22399812 | ||
| Interaction | TOP3B interactions | CCDC142 PCNX2 USP10 FASN CDK5R1 NADSYN1 SYNE3 PCNX3 TRIO PIK3C2B MTOR XPO6 RTTN SREBF1 PCNX1 NLGN2 SFI1 MLLT10 SUFU ABCA7 SCARA3 DYNC1H1 | 3.56e-07 | 1470 | 90 | 22 | int:TOP3B |
| Cytoband | 6q25.1 | 6.04e-05 | 38 | 91 | 3 | 6q25.1 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 1.01e-04 | 5 | 58 | 2 | 1333 | |
| GeneFamily | SINE class homeoboxes | 1.50e-04 | 6 | 58 | 2 | 525 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.10e-04 | 7 | 58 | 2 | 1113 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.37e-03 | 27 | 58 | 2 | 1253 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-07 | 200 | 91 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-06 | 167 | 91 | 6 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 171 | 91 | 6 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 184 | 91 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 185 | 91 | 6 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 185 | 91 | 6 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 185 | 91 | 6 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-06 | 186 | 91 | 6 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-06 | 191 | 91 | 6 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.84e-06 | 193 | 91 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-06 | 193 | 91 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 194 | 91 | 6 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 91 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 91 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 194 | 91 | 6 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.19e-06 | 197 | 91 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-06 | 199 | 91 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-06 | 200 | 91 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 1.52e-05 | 152 | 91 | 5 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-05 | 161 | 91 | 5 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-05 | 162 | 91 | 5 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-05 | 164 | 91 | 5 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-05 | 164 | 91 | 5 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 164 | 91 | 5 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-05 | 164 | 91 | 5 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 167 | 91 | 5 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 167 | 91 | 5 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-05 | 168 | 91 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-05 | 168 | 91 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC1|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-05 | 171 | 91 | 5 | 04346d4eb726875e3537e215ea081a0318ca4ddd | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 171 | 91 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-05 | 172 | 91 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.82e-05 | 173 | 91 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 175 | 91 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.07e-05 | 176 | 91 | 5 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-05 | 176 | 91 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.07e-05 | 176 | 91 | 5 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-05 | 176 | 91 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.21e-05 | 88 | 91 | 4 | fcc15c5c30517c63a835b28627c5f779d9bcd17e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.21e-05 | 88 | 91 | 4 | 7838c65160cf81c02b923fc34f566c0610c8d81b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 179 | 91 | 5 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 179 | 91 | 5 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-05 | 179 | 91 | 5 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-05 | 180 | 91 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 181 | 91 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 181 | 91 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-05 | 182 | 91 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-05 | 183 | 91 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.89e-05 | 185 | 91 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 93 | 91 | 4 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 93 | 91 | 4 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 93 | 91 | 4 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 186 | 91 | 5 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 186 | 91 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 187 | 91 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.09e-05 | 187 | 91 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 187 | 91 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 187 | 91 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 188 | 91 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 4.20e-05 | 188 | 91 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.41e-05 | 190 | 91 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | ad0f5605db6b694445ec9bd5dc8d2d834358c0f9 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 190 | 91 | 5 | 47077579496c5340e99f61499427a3a36b566da3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 191 | 91 | 5 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 191 | 91 | 5 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 191 | 91 | 5 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 191 | 91 | 5 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-05 | 191 | 91 | 5 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-05 | 192 | 91 | 5 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-05 | 192 | 91 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 192 | 91 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-05 | 192 | 91 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 193 | 91 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.76e-05 | 193 | 91 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 4.87e-05 | 194 | 91 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 4.87e-05 | 194 | 91 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 194 | 91 | 5 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 194 | 91 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 194 | 91 | 5 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 194 | 91 | 5 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 194 | 91 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 195 | 91 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.99e-05 | 195 | 91 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 4.99e-05 | 195 | 91 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 196 | 91 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 196 | 91 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-05 | 196 | 91 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 197 | 91 | 5 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-05 | 197 | 91 | 5 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| Drug | phosalone | 2.88e-07 | 15 | 89 | 4 | CID000004793 | |
| Drug | pyrenebutyl methylphosphonofluoridate | 4.77e-06 | 9 | 89 | 3 | CID000125653 | |
| Drug | chlorpyrifos-methyl | 6.79e-06 | 10 | 89 | 3 | CID000021803 | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 4962_UP | |
| Drug | carmustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.32e-05 | 199 | 89 | 7 | 6888_DN | |
| Disease | Schizophrenia | SHANK1 NDST3 SLC6A9 RELN CDK5R1 AHI1 MTOR ACHE SREBF1 GRIA1 DAAM2 NLGN2 ACE | 2.44e-06 | 883 | 89 | 13 | C0036341 |
| Disease | Acute Confusional Senile Dementia | 1.27e-05 | 99 | 89 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.27e-05 | 99 | 89 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.27e-05 | 99 | 89 | 5 | C0750901 | |
| Disease | Presenile dementia | 1.27e-05 | 99 | 89 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 1.27e-05 | 99 | 89 | 5 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.34e-05 | 100 | 89 | 5 | C0276496 | |
| Disease | Alzheimer's Disease | 1.41e-05 | 101 | 89 | 5 | C0002395 | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (is_implicated_in) | 5.38e-05 | 4 | 89 | 2 | DOID:0050997 (is_implicated_in) | |
| Disease | Intellectual Disability | 6.30e-05 | 447 | 89 | 8 | C3714756 | |
| Disease | Dysequilibrium syndrome | 8.94e-05 | 5 | 89 | 2 | C0394006 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 8.94e-05 | 5 | 89 | 2 | C3281201 | |
| Disease | Developmental Academic Disorder | 9.16e-05 | 29 | 89 | 3 | C1330966 | |
| Disease | Learning Disorders | 9.16e-05 | 29 | 89 | 3 | C0023186 | |
| Disease | Learning Disturbance | 9.16e-05 | 29 | 89 | 3 | C0751263 | |
| Disease | Adult Learning Disorders | 9.16e-05 | 29 | 89 | 3 | C0751262 | |
| Disease | Learning Disabilities | 9.16e-05 | 29 | 89 | 3 | C0751265 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.95e-05 | 152 | 89 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.64e-04 | 268 | 89 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | vitamin D deficiency | 1.91e-04 | 37 | 89 | 3 | EFO_0003762 | |
| Disease | male breast carcinoma | 2.49e-04 | 8 | 89 | 2 | EFO_0006861 | |
| Disease | Carcinoma, Small Cell | 3.19e-04 | 9 | 89 | 2 | C0262584 | |
| Disease | Kidney Failure, Chronic | 4.16e-04 | 48 | 89 | 3 | C0022661 | |
| Disease | cortical thickness | A2M GMNC NELL1 RELN ARID1B MALRD1 SREBF1 USP35 ADGRV1 CALCRL MLLT10 | 5.19e-04 | 1113 | 89 | 11 | EFO_0004840 |
| Disease | myeloid white cell count | 5.24e-04 | 937 | 89 | 10 | EFO_0007988 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.57e-04 | 53 | 89 | 3 | C1961099 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.20e-04 | 128 | 89 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.20e-04 | 128 | 89 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.20e-04 | 128 | 89 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.20e-04 | 128 | 89 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.20e-04 | 128 | 89 | 4 | C0007134 | |
| Disease | Coffin-Siris syndrome | 6.87e-04 | 13 | 89 | 2 | C0265338 | |
| Disease | Malformations of Cortical Development | 8.00e-04 | 14 | 89 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 8.00e-04 | 14 | 89 | 2 | C0431380 | |
| Disease | Liver carcinoma | 8.69e-04 | 507 | 89 | 7 | C2239176 | |
| Disease | response to irinotecan | 9.21e-04 | 15 | 89 | 2 | EFO_0004829 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.05e-03 | 16 | 89 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.07e-03 | 148 | 89 | 4 | C0279702 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.15e-03 | 68 | 89 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.18e-03 | 261 | 89 | 5 | C0004352 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.19e-03 | 17 | 89 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | ischemia (implicated_via_orthology) | 1.19e-03 | 17 | 89 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | complex trait | 1.39e-03 | 271 | 89 | 5 | EFO_0010578 | |
| Disease | Meningioma | 1.49e-03 | 19 | 89 | 2 | C0025286 | |
| Disease | epilepsy (implicated_via_orthology) | 1.52e-03 | 163 | 89 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 1.65e-03 | 20 | 89 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Lung diseases | 1.71e-03 | 78 | 89 | 3 | C0024115 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.81e-03 | 171 | 89 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | COVID-19 (is_implicated_in) | 1.82e-03 | 21 | 89 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | Arthrogryposis | 1.82e-03 | 21 | 89 | 2 | C0003886 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.84e-03 | 80 | 89 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | complement factor H-like 1 protein measurement | 2.00e-03 | 22 | 89 | 2 | EFO_0600092 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.21e-03 | 301 | 89 | 5 | DOID:684 (is_marker_for) | |
| Disease | cortical surface area measurement | GMNC NELL1 RELN ARID1B PCNX3 ATP8A2 SREBF1 USP35 ADGRV1 CALCRL SUFU | 2.38e-03 | 1345 | 89 | 11 | EFO_0010736 |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.38e-03 | 24 | 89 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | Left Ventricular Hypertrophy | 2.58e-03 | 25 | 89 | 2 | C0149721 | |
| Disease | Lymphatic Metastasis | 2.79e-03 | 26 | 89 | 2 | C0024232 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 2.79e-03 | 26 | 89 | 2 | EFO_0010366 | |
| Disease | Depressive Symptoms | 2.79e-03 | 26 | 89 | 2 | C0086132 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.92e-03 | 195 | 89 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 3.01e-03 | 27 | 89 | 2 | DOID:0050453 (implicated_via_orthology) | |
| Disease | acute kidney failure (implicated_via_orthology) | 3.01e-03 | 27 | 89 | 2 | DOID:3021 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NVGLLDQRLALQWVQ | 201 | P22303 | |
| TLQGSLLWAAGQRQQ | 866 | Q5SNV9 | |
| LLWAAGQRQQGQCLL | 871 | Q5SNV9 | |
| GQRQQGQCLLLWQAR | 876 | Q5SNV9 | |
| VDRSLLLQGWQDQGF | 181 | Q15078 | |
| LGLDLDAQQARVGQW | 1246 | P12821 | |
| DAQQARVGQWLLLFL | 1251 | P12821 | |
| IAQRGGWVAALNLGN | 171 | Q16611 | |
| WAFLKLLGANGNANI | 476 | Q8N157 | |
| SELLFQQWQRQGLVA | 396 | P07510 | |
| ILRQQGVFGDVQLGW | 1271 | Q8WXG9 | |
| GYLVGNQQAWLALRQ | 716 | Q17RM4 | |
| LGRVQEFNSGLLHWQ | 1876 | Q8NFD5 | |
| GQILWFRGLNRIQTQ | 1126 | Q01814 | |
| LRGTQLRNTQWVFGI | 271 | Q9NTI2 | |
| VQGWALTRQQLQALL | 1211 | Q8IZY2 | |
| KGNRIAQWQSFQLEG | 171 | P01023 | |
| SIGQLKIWDFRQQGN | 191 | Q8NFH3 | |
| GIQRVLFGNNLNFWL | 266 | O95803 | |
| RLQLWDIAGQERFGN | 76 | Q13637 | |
| DLWNNGNLVQDVFLG | 256 | Q15283 | |
| WENAELRGQLLGVTQ | 401 | O95153 | |
| NGGYFQQWQLLDRIL | 391 | Q86T65 | |
| IGFIQERAWLRQQGK | 541 | P16435 | |
| LQGLVLGQEFSIRWN | 891 | Q2M2H8 | |
| QRNQLLETRWSFLQG | 106 | Q6KB66 | |
| VRGLWAGQQQELVFL | 1946 | Q96RV3 | |
| CVRGLWAGQQQELIF | 1781 | A6NKB5 | |
| WAGQQQELIFLRNRN | 1786 | A6NKB5 | |
| GLWAGQQQELVFLRN | 1736 | Q9H6A9 | |
| GDESFQVGILRQWQL | 596 | Q16549 | |
| NGQLLRERNLLQQSW | 251 | Q8TDM6 | |
| ARWNEIFGNNLGALA | 96 | Q9UL01 | |
| LLGDQGWQNDDRVQV | 21 | Q6UVM3 | |
| RANVEFFNNWGIELL | 741 | Q6R327 | |
| INLWLGQRNQKHGLF | 186 | Q92832 | |
| LQANWYRIQGGQVDI | 1616 | P78509 | |
| FGQWSLGNNKDNRIQ | 576 | Q02809 | |
| GLTILQVNNWFINAR | 286 | A8K0S8 | |
| QVLQDWLGLGIYGIQ | 481 | Q15646 | |
| QGFWENVLLGEVNIR | 1596 | O00750 | |
| DSRGQLLWQIFGNQG | 966 | Q5VYJ5 | |
| NGNQLREYQLEGLNW | 856 | Q3L8U1 | |
| GVDFNWQAQALLALQ | 81 | P49450 | |
| LWGILGAIQAQQQEV | 11 | P12110 | |
| FLNQLQSGVNRWIRE | 241 | Q14204 | |
| QAGLRAWTQVLLGQA | 916 | Q14204 | |
| IDGFPRNQDNLQGWN | 91 | P30085 | |
| IFQERLLAGQQVWDA | 276 | Q8IYT3 | |
| WGQGIDIQRALQQVR | 331 | P42261 | |
| NQGFLDVVAALRWVQ | 196 | Q6UWW8 | |
| FGLELAQWLIQRGVQ | 1896 | P49327 | |
| LQDRGLWAVINNAGV | 156 | P37059 | |
| GAFVTLQIWLRQAQG | 286 | Q96IW7 | |
| AANNIVWLLSNLGGQ | 511 | P51168 | |
| VNQSLGLFLAQVRGW | 181 | Q6AZY7 | |
| VQRLEGALWGLQAQA | 146 | Q6ZMJ2 | |
| GNYGLLDQIQALRWL | 231 | Q8NFZ4 | |
| FFNGEVQAILRRNWN | 386 | Q16602 | |
| AIGRIDFLQGNQSAW | 541 | Q8NC60 | |
| FLKLGEWQLNLQGIN | 1751 | P42345 | |
| QNAQRIGAAALWALI | 2156 | Q86VV8 | |
| WALQAYQGQLLQEGA | 876 | A8K8P3 | |
| RFSGNFLVNLLGQWA | 311 | Q9H9S3 | |
| FSQLLRNFGQWLQVE | 806 | Q6ZMZ3 | |
| QLLLDAIEQFGFGNW | 76 | Q86TJ2 | |
| FWAAGLLDNRELQQA | 41 | A6NCL1 | |
| GLEWLVSLYNNNLNG | 761 | P51532 | |
| LWAQGQRLDVDQALN | 366 | P04278 | |
| ETQGRFQLLGDIWSN | 91 | Q9NYZ4 | |
| LQQGGNLERLGRFLW | 21 | Q15475 | |
| GWIQNGGLFIASNRQ | 146 | Q9UL12 | |
| QQWLQEGLELQKFGR | 1201 | Q9NRC6 | |
| LFNRAQLGIADENGW | 301 | Q9Y566 | |
| GDFAQAAQQLWLALR | 596 | P36956 | |
| ERQWSEGQQFLLEQG | 721 | P55197 | |
| LGFLLSWRQDNLNGT | 6 | O14603 | |
| IGFNNVLNVLNLAVW | 211 | Q8TBB6 | |
| LRALGLLQQQGQLWT | 91 | Q6ZTK2 | |
| LFRLNNFGLLNSNWG | 171 | Q9BVS5 | |
| VWVGGQLFQADRALL | 11 | C9JR72 | |
| QAQQVSGLLAQLWRA | 191 | Q9P2H5 | |
| LQQQGRFLAGVAWDG | 456 | Q7L0X0 | |
| AQQWNGQGILELLRT | 211 | Q9UMX1 | |
| GWIVFQRRQNGQTDF | 1176 | Q92752 | |
| ILSAGQGRCVNQWQL | 271 | Q86W42 | |
| QNLKRGNWGNQIEFV | 96 | P48067 | |
| IGLAQQWDQLYQLGL | 2236 | P02549 | |
| AQALQAAWQRLQVGL | 331 | Q86VD9 | |
| LQQGGNIERLGRFLW | 21 | Q9NPC8 | |
| LQQLNNQREWGFLCD | 11 | Q9Y2K1 | |
| QIGLNGWLRIDDQTV | 756 | Q14694 | |
| RVSNDNQFLWELIGG | 296 | P35442 | |
| IEELLNNFAQQIGAW | 31 | Q96QU8 | |
| AQGRELVFALWQQLG | 896 | Q562E7 | |
| AALALQEQWLQAGNG | 3041 | O75962 | |
| ALNQWALDFEGNLQR | 11 | Q6IA69 |